Different immunity elicited by recombinant H5N1 hemagglutinin proteins containing pauci-mannose, high-mannose, or complex type N-glycans

Highly pathogenic avian influenza H5N1 viruses can result in poultry and occasionally in human mortality. A safe and effective H5N1 vaccine is urgently needed to reduce the pandemic potential. Hemagglutinin (HA), a major envelope protein accounting for approximately 80% of spikes in influenza virus,...

Full description

Saved in:
Bibliographic Details
Published in:PloS one Vol. 8; no. 6; p. e66719
Main Authors: Lin, Shih-Chang, Jan, Jia-Tsrong, Dionne, Ben, Butler, Michael, Huang, Ming-Hsi, Wu, Chung-Yi, Wong, Chi-Huey, Wu, Suh-Chin
Format: Journal Article
Language:English
Published: United States Public Library of Science 14-06-2013
Public Library of Science (PLoS)
Subjects:
DNA
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highly pathogenic avian influenza H5N1 viruses can result in poultry and occasionally in human mortality. A safe and effective H5N1 vaccine is urgently needed to reduce the pandemic potential. Hemagglutinin (HA), a major envelope protein accounting for approximately 80% of spikes in influenza virus, is often used as a major antigen for subunit vaccine development. In this study, we conducted a systematic study of the immune response against influenza virus infection following immunization with recombinant HA proteins expressed in insect (Sf9) cells, insect cells that contain exogenous genes for elaborating N-linked glycans (Mimic) and mammalian cells (CHO). While the antibody titers are higher with the insect cell derived HA proteins, the neutralization and HA inhibition titers are much higher with the mammalian cell produced HA proteins. Recombinant HA proteins containing tri- or tetra-antennary complex, terminally sialylated and asialyated-galactose type N-glycans induced better protective immunity in mice to lethal challenge. The results are highly relevant to issues that should be considered in the production of fragment vaccines.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Competing Interests: The authors have declared that no competing interests exist.
Conceived and designed the experiments: SCL SCW. Performed the experiments: SCL JTJ BD. Analyzed the data: BD MB CYW CHW. Contributed reagents/materials/analysis tools: MHH. Wrote the paper: SCL SCW.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0066719